EC
Euclidean Capital Portfolio holdings
AUM
$306M
This Quarter Return
-12.16%
1 Year Return
+16.69%
3 Year Return
+17.66%
5 Year Return
–
10 Year Return
–
AUM
$107M
AUM Growth
+$107M
(-0.77%)
Cap. Flow
+$24.1M
Cap. Flow
% of AUM
22.54%
Top 10 Holdings %
Top 10 Hldgs %
99.56%
Holding
11
New
1
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
iShares MSCI India ETF
INDA
|
$24.1M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 73.53% |
| 2 | Financials | 3.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
iShares MSCI India ETF
INDA
$9.17B
| $24.1M | 22.54% |
+577,144
| New | +$24.1M |
|
|
ME
2
DELISTED
23andMe Holding Co. Class A Common Stock
ME
| $22.1M | 20.7% |
10,243,122
| – | – |
|
3
PMV Pharmaceuticals
PMVP
$74.2M
| $20.3M | 19.02% |
2,336,909
| – | – |
|
4
Alector
ALEC
$238M
| $9.05M | 8.47% |
980,894
| – | – |
|
5
RAPT Therapeutics
RAPT
$188M
| $8.57M | 8.02% |
432,900
| – | – |
|
6
Foghorn Therapeutics
FHTX
$286M
| $8.05M | 7.53% |
1,261,261
| – | – |
|
7
Oric Pharmaceuticals
ORIC
$994M
| $4.4M | 4.12% |
747,550
| – | – |
|
8
First Financial Bancorp
FFBC
$2.51B
| $4.21M | 3.93% |
173,576
| – | – |
|
|
NGM
9
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $3.75M | 3.51% |
746,674
| – | – |
|
10
Tenaya Therapeutics
TNYA
$184M
| $1.84M | 1.72% |
915,705
| – | – |
|
11
Surrozen
SRZN
$104M
| $467K | 0.44% |
802,963
| – | – |
|